Push for expansion of safe injecting facilities Researchers say ‘substantial evidence’ should encourage governments, in Australia and further afield, to facilitate more medically supervised sites.
Australia’s first fixed pill-testing site opens in ACT The Chair of RACGP Specific Interests Addiction Medicine has welcomed the ‘highly significant’ launch, which is part of a six-month trial.
RACGP calls for action on drug reform None of the 109 recommendations presented to the NSW Government from an inquiry into methamphetamine use have been acted upon.
Study highlights vaping harms – and evidence gaps A new systemic review says e-cigarettes can be a ‘gateway’ to greater tobacco use, but researchers say many unknowns remain.
Calls for further recognition of GPs’ contribution to AOD workforce The RACGP’s latest recommendations include higher MBS rebates for AOD consultations and extended funding for its education program.
Opioids ease osteoarthritis pain only slightly: Research Their deadly risks need to be weighed against any benefit, according to the authors of a new Australian study.
Should Australia follow New Zealand’s lead on smoking? New plans could make it illegal for tobacco ever to be sold to anyone born after 2008. Two GPs consider whether Australia should follow suit.
Has COVID-19 changed Australia’s alcohol consumption? Emerging studies are starting to reveal what impact the pandemic has had on alcohol use, writes Dr Shani Macaulay.
Approaching difficult conversations with patients about opioid use NPS MedicineWise medical advisor Dr Caroline West speaks with Dr Richard O’Regan, an addiction medicine consultant with the Royal Perth Bentley Group about opioid addiction.
Opioid treatment study ‘may impact’ future Australian guidelines Results from a clinical trial of extended-release buprenorphine injections reveal high retention and treatment satisfaction.